Comprehensive Psychiatry
Volume 52, Issue 3 , Pages 280-287 , May 2011

Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication

  • Martha Sajatovic

      Affiliations

    • Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, University Hospitals Case Medical Center, Cleveland, OH 44106, USA. Tel.: +1 216 844 2808; fax: +1 216 844 2742.
    • ,
  • Jennifer Levin

      Affiliations

    • Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    • ,
  • Edna Fuentes-Casiano

      Affiliations

    • Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    • ,
  • Kristin A. Cassidy

      Affiliations

    • Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    • ,
  • Curtis Tatsuoka

      Affiliations

    • Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    • ,
  • Janis H. Jenkins

      Affiliations

    • Department of Anthropology, University of California, San Diego, CA 92093, USA

References 

  1. American Psychiatric Association . Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159:1–50
  2. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105:164–172
  3. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J.Clin.Psychiatry. 2002;63:384–390
  4. Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(Suppl 4):1–46[quiz 47-8]
  5. Sajatovic M, Valenstein M, Blow FC, et al. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006;8:232–241
  6. Sajatovic M, Valenstein M, Blow F, et al. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv. 2007;58:855–863
  7. Berk M, Berk L, Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord. 2004;6:504–518
  8. Sajatovic M, Jenkins JH, Cassidy KA, Muzina DJ. Medication treatment perceptions, concerns and expectations among depressed individuals with type I bipolar disorder. J Affect Disord. 2009;115:360–366
  9. Depp CA, Moore DJ, Patterson TL, et al. Psychosocial interventions and medication adherence in bipolar disorder. Dialogues Clin Neurosci. 2008;10:239–250
  10. Clatworthy J, Bowskill R, Rank T, et al. Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment. Bipolar Disord. 2007;9:656–664
  11. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33[quiz 34-57]
  12. Peet M, Harvey NS. Lithium maintenance: 1. A standard education programme for patients. Br J Psychiatry. 1991;158:197–200
  13. Jenkins JH, Strauss ME, Carpenter EA, et al. Subjective experience of recovery from schizophrenia-related disorders and atypical antipsychotics. Int J Soc Psychiatry. 2005;51:211–227
  14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  15. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435
  16. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799–812
  17. Guy W. Clinical global impressions. In:  Guy W editors. ECDEU assessment manual for psychopharmacology. Rockville, MD: Department of Health, Education, and Welfare, DHEW; 1976;p. 76–338
  18. Adams J, Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 2000;101:119–124
  19. Awad AG. Subjective response to neuroleptics in schizophrenia. Schizophr Bull. 1993;19:609–618
  20. Weiden P, Rapkin B, Mott T, et al. Rating of Medication Influences (ROMI) scale in schizophrenia. Schizophr Bull. 1994;20:297–310
  21. Harvey NS. The development and descriptive use of the lithium attitudes questionnaire. J Affect Disord. 1991;22:211–219
  22. Sajatovic M, Ignacio RV, West JA, et al. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry. 2009;50:100–107
  23. Muhr T. Atlas.ti software development. 1993;www.atlasti.com
  24. Luborsky MR. The identification and analyses of themes and patterns. In:  Gubrium J,  Snakar A editor. Qualitative methods in aging research. New York: Sage Publications; 1993;p. 189–210
  25. Good B. Medicine, rationality & experience. Cambridge, MA: Cambridge University Press; 1994;
  26. Copeland LA, Zeber JE, Salloum IM, et al. Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis. 2008;196:16–21
  27. Sajatovic M, Velligan DI, Weiden PJ, et al. Measurement of psychiatric treatment adherence. J Psychosom Res. 2009;
  28. Berk M, Hallam K, Lucas N, et al. Early intervention in bipolar disorders: opportunities and pitfalls. Med J Aust. 2007;187:S11–14
  29. Depression and Bipolar Support Alliance/DBSA: website homepage. Depression and Bipolar Support Alliance/DBSA: website homepage. Available at:www.dbsalliance.org [March 302009].
  30. Bauer MS, Kilbourne AM, Greenwald DE, et al. Overcoming bipolar disorder: a comprehensive workbook for managing your symptoms and achieving your life goals. Oakland, CA: New Harbinger Publications, Inc.; 2008;
  31. Colom F, Vieta E, Martinez , Aran A, et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry. 2003;60:402–407
  32. Zeber JE, Copeland LA, Good CB, et al. Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. J Affect Disord. 2008;107:53–62
  33. Horsfall J, Cleary M, Hunt GE, Walter G. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harv Rev Psychiatry. 2009;17:24–34
  34. Darling CA, Olmstead SB, Lund VE, Fairclough JF. Bipolar disorder: medication adherence and life contentment. Arch Psychiatr Nurs. 2008;22:113–126
  35. Sachs GS. Psychosocial interventions as adjunctive therapy for bipolar disorder. J Psychiatr Pract. 2008;14(Suppl 2):39–44
  36. Byerly M, Fisher R, Whatley K, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 2005;133:129–133
  37. Sajatovic M, Biswas K, Kilbourne AK, et al. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr Serv. 2008;59:753–759
  38. Sherman LW, Strang H. Experimental ethnography: the marriage of qualitative and quantitative research. Ann Am Acad Polit Soc Sci. 2004;595:204–222

 Portions of this article have been presented at the American Psychiatric Association annual meeting in San Francisco, CA, USA, May 2009 and the 9th World Congress of Biological Psychiatry, Paris, France, June 2009.

 This research was supported by NIMH R34 5R34MH078967, P.I.:M. Sajatovic.

PII: S0010-440X(10)00093-3

doi: 10.1016/j.comppsych.2010.07.002

Comprehensive Psychiatry
Volume 52, Issue 3 , Pages 280-287 , May 2011

Article Tools

* Image Usage & Resolution